Statins and the treatment of mCRPC with chemotherapy

A report on the UroToday web site has addressed a presentation given this week at the ESMO 2018 Congress in Munich, Germany, that is relevant to the potential value of taking a statin while you are being treated for very late stage prostate cancer. … READ MORE …

How doctors interpret published data from clinical trials of new drugs

Although it has nothing to do with prostate cancer in particular, there is an interesting article in this week’s issue of the New England Journal of Medicine that assesses how physicians interpret the published results of clinical trials of new drugs — based on the quality of the trials (their “rigor”) and who put up the money to carry the trial out (“funding”). … READ MORE …